Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Hitomi Sumiyoshi Okuma"'
The Selangor Consensus: strengthening clinical trials for local public health in the Western Pacific
Autor:
Kidong Park, Mengji Chen, Jinho Shin, Gui Xian Ong, Vasee Moorthy, Wei Zhang, Bin Cao, Chia Wei Phan, Chun Keat Chew, Fiona Russell, Ganzorig Dorjdagva, Hani Kim, Hitomi Sumiyoshi Okuma, Hyun-Young Park, Iris Conela Tagaro, Jing Li, Jungyeon Kim, Justin Im, Koji Wada, Koukeo Phommasone, Li Yang Hsu, Philip Rajan Devesahayam, Robyn Whittaker, Saiful Safuan Md Sani, Sheamini Sivasampu, Sushant Sahastrabuddhe, Vonthanak Saphonn, Yin Mo, Zaril Harza Zakaria
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 48, Iss , Pp 101136- (2024)
Externí odkaz:
https://doaj.org/article/b0e32b275b0f4ca0aeceb40f9e70285e
Autor:
Sho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Kazuki Sudo, Emi Noguchi, Akihiko Yoshida, Akira Kawai, Yasuhiro Fujiwara, Kan Yonemori
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Prognostic value of hematologic indices and their association with the tumor microenvironment (TME) remain unclear in advanced soft tissue sarcoma (STS). We aimed to evaluate their prognostic value and correlation with the TME status in adva
Externí odkaz:
https://doaj.org/article/7169a5aae4cb428bbaf374a0faa34c96
Autor:
Shigemasa Takamizawa, Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Rui Kitadai, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Hitomi Sumiyoshi Okuma, Maki Tanioka, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Kan Yonemori
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Mesothelin (MSLN) is a cell-surface glycoprotein found in various solid tumours. Cancer therapies targeting MSLN have been developed in recent years; however, the available information on MSLN expression in cervical cancer is limi
Externí odkaz:
https://doaj.org/article/0d1ff421865b4a71af51806eb508282d
Autor:
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, Asuka Kawachi, Shu Yazaki, Momoko Tokura, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Aiko Maejima, Yuki Kojima, Tadaaki Nishikawa, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi, Yasuhiro Fujiwara, Hirokazu Sugino, Sho Shiino, Akihiko Suto, Masayuki Yoshida, Kan Yonemori
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionTriple-negative breast cancer (TNBC) is negative for hormone receptors and human epidermal growth factor receptor 2 (HER2). In stage I TNBC, adjuvant therapy or follow-up are performed according to risk factors, but clinical trial data is
Externí odkaz:
https://doaj.org/article/d1c7862b911d4555b6a5240fa9cffc46
Autor:
Hitomi Sumiyoshi Okuma, Kan Yonemori, Yuki Kojima, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Susumu Hijioka, Keiko Wakakuwa, Ken Kato, Akihiro Hirakawa, Aya Kuchiba, Takashi Kubo, Hitoshi Ichikawa, Akihiko Yoshida, Yasushi Yatabe, Kenichi Nakamura, Hiroyuki Mano, Noboru Yamamoto, Yasuhiro Fujiwara
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposePatients with advanced/relapsed rare cancers have few treatment options. Analysis of circulating tumor DNA in plasma may identify actionable genomic biomarkers using a non-invasive approach.Patients and MethodsRare cancer patients underwent pr
Externí odkaz:
https://doaj.org/article/35ecf0472ced44858aa96591a8e7fa2a
Publikováno v:
International Cancer Conference Journal. 12:216-219
Autor:
Mitsumi Terada, Kenichi Nakamura, Tomohiro Matsuda, Hitomi Sumiyoshi Okuma, Kazuki Sudo, Akhmal Yusof, Marcelo Imasa, Ekaphop Sirachainan, Pham Tuan Anh, Yasuhiro Fujiwara, Noboru Yamamoto, Pei Jye Voon, Kulkanya Chokephaibulkit, Tatsuhiro Shibata, Manami Inoue, Hiroyuki Mano, Tatsunori Shimoi, Virote Sriuranpong, Kan Yonemori, Kazuaki Shimada
Publikováno v:
Japanese Journal of Clinical Oncology.
This report summarizes the presentations and discussions in the first Asian Clinical Trials Network for Cancers (ATLAS) international symposium that was held on 24 April 2022, in Bangkok, Thailand, and hosted by the National Cancer Center Hospital (N
Autor:
Hitomi Sumiyoshi Okuma, Hiroshi Yoshida, Yoshihisa Kobayashi, Motoko Arakaki, Chiharu Mizoguchi, Lina Inagaki, Pei Jye Voon, Adam Malik Bin Ismail, Hwoei Fen Soo Hoo, Suhana Yusak, Marcelo Severino B. Imasa, Thinh Nguyen Huy, Tu Thai Anh, Shinji Kohsaka, Hiroyuki Mano, Kan Yonemori, Kenichi Nakamura, Yasushi Yatabe
Publikováno v:
Cancer Science.
Autor:
Yohei Chiba, Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Ayumi Saito, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Kan Yonemori
Publikováno v:
Translational research/biomarkers.
Autor:
Shu Yazaki, Tatsunori Shimoi, Masayuki Yoshida, Hitomi Sumiyoshi-Okuma, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Sho Shiino, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Yasuhiro Fujiwara, Kan Yonemori
Publikováno v:
Breast cancer research and treatment. 197(2)
Purpose Stromal tumor-infiltrating lymphocytes (TILs) are independent prognostic factors in systemically untreated early-stage triple-negative breast cancer (TNBC). Other immune biomarkers including CD8, CD20, programmed cell death-ligand 1 (PD-L1),